AFCRI NEWS

 

The Abramson Family Cancer Research Institute at the University of Pennsylvania Cancer Center

Cells of Aggressive Leukemia Hijack Normal Protein to Grow, According to Penn Study


PHILADELPHIA - Researchers have found that one particularly aggressive type of blood cancer, mixed lineage leukemia (MLL), has an unusual way to keep the molecular motors running. The cancer cells rely on the normal version of an associated protein to stay alive. (more)

More AFCRI news

Stay Connected to AFCRI

AFCRI on twitter
twitter
AFCRI on YouTube
Youtube


facebook



EVENTS

Abramson Family Cancer Research Institute Events

 

Learn more

RESEARCH AREAS AND STUDY PROGRAMS

 

Share |

OUR HISTORY AND MISSION


Our mission is to create knowledge through research and to provide compassionate care in the prevention, diagnosis, and treatment of cancer.

The Abramson Cancer center of the University of Pennsylvania provides each patient with exemplary care though a comprehensive team approach, personalized service, education and outreach, and nationally recognized cancer research programs.

A small group of dedicated cancer specialists established Penn's Cancer Center in 1973 to offer patients new, innovative treatments in an integrated research environment. Today, more than 500 research and clinical specialists work at the center, all dedicated to preventing, diagnosing, and curing cancer. Our focus on patients combined with our cutting-edge research and vast technological knowledge, have won us the prestigious designation of "Comprehensive Cancer Center" by the National Cancer Institute continuously for over 30 years.

Penn's Cancer Center was renamed in 2002 as the Abramson Cancer Center of the University of Pennsylvania, recognizing the Abramson family's $100 million commitment to support comprehensive cancer research and care.

Compassion and innovation guide our clinical program, where physicians from all disciplines, nurse practitioners, nurses, social workers, physical therapists, nutritionists, and patient care coordinators oversee 50,000 outpatient visits and 3,400 inpatient admissions each year, plus more than 89,000 chemotherapy and radiation treatments.